SEC Form 4 · accession 0001209191-16-099211
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick C. Roche
Officer — SVP Research & Development
Period of report
Feb 16, 2016
Accepted (ET)
Feb 17, 2016 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.36 | Feb 16, 2016 | A | 85,000 | A | — | Feb 15, 2026 | Common Stock | 85,000 | 85,000 | D |
Explanation of responses
- F1One-sixteenth (1/16th) of the shares vest on February 16, 2016; thereafter, the shares vest in a series of fifteen (15) successive equal quarterly installments on the last day of each calendar quarter, commencing with the last day of the calendar quarter first occurring after February 16, 2016.